In this study, we analyzed over 880 thousand RA reports from FDA Adverse Event Reporting System (FAERS) and quantifed the evidence using the latest population scale dataset for a statistically significant association of psoriasis with TNF inhibitor use. Here, TNF is linked to rheumatoid arthritis.